Biomarin Pharmaceutical Inc Cash Flow Quality Index
Biomarin Pharmaceutical Inc cash flow quality index. Biomarin Pharmaceutical Inc (BMRN) has a Cash Flow Quality Index of 3.76x as of June 2026. Operating cash flow of $168.11 Million exceeds net income of $44.76 Million, indicating high earnings quality where cash backs reported profits. See BMRN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Biomarin Pharmaceutical Inc (2008–2025)
Cash flow quality index of Biomarin Pharmaceutical Inc from 2008 to 2025. Historical Cash Flow Quality Index for Biomarin Pharmaceutical Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Biomarin Pharmaceutical Inc (BMRN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Biomarin Pharmaceutical Inc Cash Flow Quality Index by Year (2008–2025)
Biomarin Pharmaceutical Inc cash flow quality index by year from 2008 to 2025. Year-by-year earnings quality comparison for Biomarin Pharmaceutical Inc. For the full cash flow conversion analysis, see Biomarin Pharmaceutical Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.37x | $827.99 Million | $348.90 Million | ▲ +76.8% |
| 2024 | 1.34x | $572.84 Million | $426.86 Million | ▲ +41.3% |
| 2023 | 0.95x | $159.26 Million | $167.65 Million | ▼ -23.5% |
| 2022 | 1.24x | $175.90 Million | $141.56 Million | ▲ +1150.5% |
| 2020 | 0.10x | $85.36 Million | $859.10 Million | ▲ +9.1% |
| 2010 | 0.09x | $18.75 Million | $205.82 Million | ▲ +130.6% |
| 2008 | -0.30x | $-9.18 Million | $30.83 Million | — |